ICLR · Icon PLC
Market Cap
$13.30B
Shares
77.15M
Volume · Oct 5
932.59K
Avg daily vol (3M)
805.44K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$162.05
Open$161.85
Day$160.41–163.43
52W close$80.08–202.92
Avg vol 30d886K
Short int2.6M · 3.4% float · 2.8d
Short vol44%
Last earningsJul 30, 2026
DataJan 2020–Oct 2026
Up next
call held Jul 30, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$8.29B
Trailing 12 months
Net income (TTM)
$42.34M
Trailing 12 months
Revenue growth YoY
+1.2%
Year over year
Operating margin
3.6%
Trailing 12 months
P / E (TTM)
249.3
Trailing earnings · reciprocal yield 0.4%
FCF yield
6.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.7%
Year over year · fewer shares
Price change (1Y)
-16.0%
Trailing year
Short interest
3.4%
Latest settlement · 2.8 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Strong
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
−3%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
67%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
+47%
trailing
YTD return
−11%
this year
Relative strength
+35%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $167 › 200d $146 — 50d above 200d
Institutional flow
Distributing
3 of 429 funds reported for Sep 30 · net -1.7K sh shares
Insider flow
Distributing
Net -$4.0M over 90 days · 100% sells
Short interest
Rising
3.40% of float · ▲ +10.4% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
429 holders — near 3-yr low, contrarian setup
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
EPS growth
−67%
Y/Y
Free cash flow
$862.0M
Valuation
P/E 265.1
rich
Buyback
$750.0M
remaining
Balance sheet
$3.4B
net debt
Quant / Vol
risk profile
Volatility
67%
annualized · 1-yr
Max drawdown
−61%
past year
ATR
4.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 24, 2026
Revenue
· full year 2026
Initiated
$7.85B – $8.15B
prior FY $8.25B
midpoint −3.0% Y/Y
Adjusted diluted earnings per share
· full year 2026
Non-GAAP
Initiated
$10.00 – $11.00
Guided vs delivered
· last 5 settled
Full year revenue
full year
guided $8.05B – $8.1B
$8.25B
Beat +2.2%
Revenue guidance
2021
guided $5.43B – $5.53B
$5.48B
In line
2020 revenue
2020
guided $2.75B – $2.81B
$2.8B
In line
Earnings per share
2020
guided $6.00 – $6.50
$6.15
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
−3%
Neutral
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
67%
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $167 › 200d $146 — 50d above 200d
Institutional flow
Distributing
3 of 429 funds reported for Sep 30 · net -1.7K sh shares
Insider flow
Distributing
Net -$4.0M over 90 days · 100% sells
Short interest
Rising
3.40% of float · ▲ +10.4% MoM · 2.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
429 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $80
Now $162 · 67%
Range high $203
vs 200-day avg +11%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ICLR
this stock
Icon PLC
|
$13.30B | -11.1% | +19.8% | 265.1 | 3.4% |
|
TMO
Thermo Fisher Scientific Inc.
|
$249.58B | +13.0% | +14.5% | 36.3 | 1.4% |
|
DHR
Danaher Corp /De/
|
$150.37B | -6.5% | +8.5% | 37.9 | 1.2% |
|
NTRA
Natera, Inc.
|
$59.47B | +79.1% | -2.8% | — | 3.3% |
|
A
Agilent Technologies, Inc.
|
$48.90B | +23.3% | +6.4% | 34.2 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ICLR | -6.0% | -0.9% | +46.8% | -4.7% | -11.1% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -5.8% | -0.5% | +34.6% | -5.6% | -23.9% |
Capital returns
Buyback programs
· 4 active
· as of Jun 30, 2026
Authorized (total)
$2.50B
Spent (derived)
$1.75B
Remaining
$750.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1060955
CUSIP
G4705A100
13F (30d)
15 filings
7 filers
Visit website
Investor relations